GIP-3 a cutting-edge triple receptor agonist designed to support significant weight loss, improve glycemic control, and enhance overall metabolic health, offering a comprehensive solution for those seeking advanced treatment with GLP-1 therapy.
$374.99
You save
Historically referenced in research as “Retatrutide,” this peptide is now more precisely described by its mechanism of action: GIP-3.
GIP-3 is a novel peptide currently under investigation for its potential in supporting weight management and metabolic health. It functions as a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors, similar to other incretin-based therapies. By targeting these pathways, GIP-3 may enhance insulin sensitivity, promote weight reduction, and improve glycemic control. The synergistic activation of both GLP-1 and GIP receptors is believed to offer superior regulation of blood glucose and appetite compared to traditional single-pathway approaches. Ongoing studies continue to explore its safety, efficacy, and broader applications in obesity and type 2 diabetes research, positioning GIP-3 as a promising candidate in next-generation metabolic therapy development.
Please note: This peptide is provided in its lyophilized (freeze-dried) white powder form for maximum stability. For optimal preparation, we recommend pairing it with our premium bacteriostatic water available separately under reconstitution solutions.
GIP-3 a cutting-edge triple receptor agonist designed to support significant weight loss, improve glycemic control, and enhance overall metabolic health, offering a comprehensive solution for those seeking advanced treatment with GLP-1 therapy.
GIP-3 – Triple Receptor Agonist for Metabolic Research
GIP-3 is an investigational peptide designed as a triple agonist targeting GLP-1, GIP, and glucagon receptors. Research has focused on its potential role in metabolic regulation, energy balance, and glucose pathways.
Key Research Areas:
GIP-3 is a research peptide being studied for its potential metabolic applications. Based on preclinical data from related GLP analogs, reported effects in research models may include:
Nausea or digestive discomfort
Diarrhea or constipation
Fatigue or headache
Appetite suppression
Mild dizziness
These observations are drawn from animal and laboratory studies involving structurally similar compounds. GIP-3 is not approved for human use and is offered strictly for research purposes only.
Chemical Name: GIP-3 15mg
Chemical Formula: C223H343F3N46O70
Molecular Mass: 4845.44 g·mol⁻¹
Total Amount of Active Ingredient: 15.21mg
Appearance: Lyophilized peptide powder
Shelf Life: 36 months (about 3 years)
Verified Purity: 99.783% (COA #22342)
View Verified Certificate of Analysis
| Weight | 6 g |
|---|---|
| Dimensions | .8 × .8 × 1.5 in |
You must be logged in to post a review.
End of Content.
End of Content.
Reviews
There are no reviews yet.